ADMA Biologics, Inc.
US ˙ NasdaqGM ˙ US0008991046

SecurityADMA / ADMA Biologics, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership2,344,899 shares
Latest Disclosed Value $ 21,127,540
Franklin Resources Inc reports 16.07% decrease in ownership of ADMA / ADMA Biologics, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 2,344,899 shares of ADMA Biologics, Inc. (US:ADMA) valued at $21,127,540 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 2,793,856 shares of ADMA Biologics, Inc.. This represents a change in shares of -16.07% during the quarter. The current value of the position is $18,196,416 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ADMA BIOLOGICS COM 000899104 2,344,899 -448,957 -16.07 21,128 -58.54 0.0008
2026-02-11 2025-12-31 13F ADMA BIOLOGICS COM 000899104 2,793,856 -44,287 -1.56 50,960 -51.14 0.0125
2025-11-13 2025-09-30 13F AAR COM 000899104 2,838,143 119,127 4.38 104,305 110.66 0.0260
2025-08-12 2025-06-30 13F ADMA BIOLOGICS COM 000899104 2,719,016 1,085,286 66.43 49,513 52.76 0.0131
2025-05-13 2025-03-31 13F ADMA BIOLOGICS COM 000899104 1,633,730 1,306,719 399.59 32,413 477.98 0.0093
2025-02-12 2024-12-31 13F ADMA BIOLOGICS COM 000899104 327,011 159,367 95.06 5,608 104.37 0.0016
2024-11-27 2024-09-30 13F/A-1 ADMA BIOLOGICS COM 000899104 167,644 27,180 19.35 2,744 74.78 0.0008
2024-11-12 2024-09-30 13F ADMA BIOLOGICS COM 000899104 167,644 27,180 2,744 0.0001
2024-08-14 2024-06-30 13F ADMA BIOLOGICS COM 000899104 140,464 22,575 19.15 1,570 101.80 0.0005
2024-05-13 2024-03-31 13F ADMA BIOLOGICS COM 000899104 117,889 21,967 22.90 778 79.68 0.0002
2024-02-09 2023-12-31 13F ADMA BIOLOGICS COM 000899104 95,922 0 0.00 434 26.24 0.0002
2023-11-13 2023-09-30 13F ADMA BIOLOGICS COM 000899104 95,922 -4,787 -4.75 343 -7.55 0.0002
2023-08-11 2023-06-30 13F ADMA BIOLOGICS COM 000899104 100,709 100,709 372 0.0002
2021-08-13 2021-06-30 13F ADMA BIOLOGICS COM 000899104 0 -440,201 -100.00 0 -100.00
2021-05-13 2021-03-31 13F ADMA BIOLOGICS COM 000899104 440,201 -593,591 -57.42 775 -61.56 0.0003
2021-02-10 2020-12-31 13F ADMA BIOLOGICS COM 000899104 1,033,792 128 0.01 2,016 -18.38 0.0009
2020-11-12 2020-09-30 13F ADMA BIOLOGICS COM 000899104 1,033,664 0 0.00 2,470 -20.88 0.0012
2020-08-13 2020-06-30 13F ADMA BIOLOGICS COM 000899104 1,033,664 0 0.00 3,122 4.87 0.0016
2020-05-13 2020-03-31 13F ADMA BIOLOGICS COM 000899104 1,033,664 1,033,664 0.00 2,977 -4.64 0.0020
2017-11-13 2017-09-30 13F ADMA BIOLOGICS COM 000899104 0 -348,870 -100.00 0 -100.00
2017-08-10 2017-06-30 13F ADMA BIOLOGICS COM 000899104 348,870 -10,629 -2.96 1,340 -23.60 0.0007
2017-05-12 2017-03-31 13F ADMA BIOLOGICS COM 000899104 359,499 0 0.00 1,754 -4.73 0.0009
2017-02-14 2016-12-31 13F ADMA BIOLOGICS COM 000899104 359,499 0 0.00 1,841 -29.36 0.0010
2016-11-14 2016-09-30 13F ADMA BIOLOGICS COM 000899104 359,499 0 0.00 2,606 21.83 0.0014
2016-08-11 2016-06-30 13F ADMA BIOLOGICS COM 000899104 359,499 0 0.00 2,139 -26.44 0.0012
2016-05-10 2016-03-31 13F ADMA BIOLOGICS COM 000899104 359,499 104,500 40.98 2,908 40.62 0.0015
2016-04-27 2015-12-31 13F/A-1 ADMA BIOLOGICS COM 000899104 254,999 -9,100 -3.45 2,068 -6.34 0.0010
2016-02-12 2015-12-31 13F ADMA BIOLOGICS COM 000899104 254,999 2,068
2015-11-10 2015-09-30 13F ADMA BIOLOGICS COM 000899104 264,099 -93,400 -26.13 2,208 -33.29 0.0011
2015-08-12 2015-06-30 13F ADMA BIOLOGICS COM 000899104 357,499 0 0.00 3,310 -5.51 0.0015
2015-05-14 2015-03-31 13F ADMA BIOLOGICS COM 000899104 357,499 -2,638 -0.73 3,503 -12.93 0.0016
2015-02-10 2014-12-31 13F ADMA BIOLOGICS COM 000899104 360,137 360,137 4,023 0.0018
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.